MedPath
FDA Approval

Diphenhydramine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 3, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Diphenhydramine(50 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC

840771732

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenhydramine

Product Details

NDC Product Code
63323-664
Application Number
ANDA040466
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
October 3, 2019
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: TC2D6JAD40Class: ACTIBQuantity: 50 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath